ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Must-Watch Stocks Right Now. ImmunityBio surged by 7.29 percent on Friday to finish at $8.39 apiece, as investors took heart from the company’s optimism ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer ...
The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in metastatic prostate cancer session and a presentation by Dr. Rodrigo España Navarro ...
MedPage Today on MSN
COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?
News, features, and commentary about cancer-related issues ...
A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.
Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
Microplastics have now been found inside most prostate cancer tumors — and at strikingly higher levels than in healthy tissue.
A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...
A large international study has mapped the genetic landscape of feline cancers for the first time, revealing striking similarities between tumor-driving mutations in cats, humans, and dogs.
Everyday Health on MSN
Severe Flu or COVID-19 Could Raise Lung Cancer Risk
In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results